The Food & Drug Administration and Centers for Disease Control have called for a pause of the rollout of Johnson & Johnson's (JNJ) - Get Johnson & Johnson (JNJ) Report vaccine following concerns around a rare blood clotting issue that has impacted six women. Nearly seven million doses of Johnson & Johnson's vaccine have been administered, per CDC data
"The CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance," the agencies said in a joint statement. "The FDA will review that analysis as it also investigates these cases. Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution."
Watch TheStreet Live: Everything Jim Cramer Is Watching Tuesday.
Curious about what Jim Cramer and his team at Action Alerts PLUS are watching in the markets? Watch Cramer's exclusive members-only Daily Rundown show on Action Alerts PLUS following TheStreet Live.